Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.090 USD | -5.22% | +6.86% | -46.57% |
09-12 | Scilex Gets Drug Distributor Accreditation from National Association of Boards of Pharmacy | MT |
09-03 | Scilex Unit Semnur Pharmaceuticals, Denali Capital Sign Merger Agreement | MT |
Company Valuation: Scilex Holding Company
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 564 | 199.6 | 143.6 | - | - |
Change | - | -64.61% | -28.06% | - | - |
Enterprise Value (EV) | 564 | 199.6 | 143.6 | 143.6 | 143.6 |
Change | - | -64.61% | -28.06% | 0% | 0% |
P/E ratio | -23.5x | -1.59x | -0.92x | -2.44x | -2.45x |
PBR | - | - | - | - | - |
PEG | - | -0x | 0.13x | 0x | 6.55x |
Capitalization / Revenue | - | 4.27x | 2.33x | 1.49x | 1.43x |
EV / Revenue | - | 0x | 2.33x | 1.49x | 1.43x |
EV / EBITDA | - | - | - | - | - |
EV / EBIT | - | -0x | -1.58x | -1.88x | -2.2x |
EV / FCF | - | -0x | -1.17x | -1.3x | -2.14x |
FCF Yield | - | -10.4% | -85.8% | -77.2% | -46.7% |
Dividend per Share 2 | - | - | - | - | - |
Rate of return | - | - | - | - | - |
EPS 2 | -0.17 | -1.28 | -1.19 | -0.4467 | -0.445 |
Distribution rate | - | - | - | - | - |
Net sales 1 | - | 46.74 | 61.6 | 96.48 | 100.1 |
EBITDA | - | - | - | - | - |
EBIT 1 | - | -105.4 | -91.05 | -76.47 | -65.19 |
Net income 1 | -23.36 | -114.3 | -102.1 | -89.37 | -80.64 |
Net Debt | - | - | - | - | - |
Reference price 2 | 3.990 | 2.040 | 1.090 | 1.090 | 1.090 |
Nbr of stocks (in thousands) | 141,349 | 97,837 | 131,722 | - | - |
Announcement Date | 3/7/23 | 3/12/24 | - | - | - |
P/E ratio, Detailed evolution
P/E ratio | EV / Sales | EV / EBITDA | Yield (Y) | Capi. ($) | ||
---|---|---|---|---|---|---|
-0.97x | - | - | - | 151M | ||
24.46x | 3.74x | 13.22x | +1.37% | 81.08B | ||
25.17x | 2.83x | 12x | +1.79% | 12.2B | ||
62.44x | 4.51x | 53.15x | +0.33% | 7.07B | ||
114.59x | 15.22x | 83.23x | -.--% | 6.15B | ||
33.86x | 6.09x | 18.9x | +0.66% | 2.32B | ||
11.2x | - | - | +17.86% | 1.91B | ||
27.95x | - | - | - | 1.77B | ||
107.28x | - | - | - | 1.71B | ||
Average | 45.11x | 6.48x | 36.10x | +3.67% | 12.71B | |
Weighted average by Cap. | 32.97x | 4.39x | 19.76x | +1.54% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- SCLX Stock
- Valuation Scilex Holding Company
MarketScreener is also available in this country: United States.
Switch edition